Vitamin C and community-acquired pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 5, 2011, Pages 621-622

  Hemilä, Harri ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID;

ARTIFICIAL VENTILATION; COMMUNITY ACQUIRED PNEUMONIA; CRITICALLY ILL PATIENT; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; INCIDENCE; LETTER; MORTALITY; NUTRITION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL PATIENT; TREATMENT OUTCOME;

EID: 80052468959     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/ajrccm.184.5.621a     Document Type: Letter

References (5)

1. Waterer GW, Rello J, Wunderink RG. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med 2011;183:157-164.
2. Hemilä H. Do vitamins C and E affect respiratory infections? [Dissertation] Helsinki, Finland: University of Helsinki; 2006. pp. 5-9, 105-121.
3. Hunt C, Chakravorty NK, Annan G, Habibzadeh N, Schorah CJ. The clinical effects of vitamin C supplementation in elderly hospitalised patients with acute respiratory infections. Int J Vitam Nutr Res 1994;64: 212-219.
4. Hemilä H, Louhiala P. Vitamin C for preventing and treating pneumonia. Cochrane Database Syst Rev 2007;1:CD005532.
5. Nathens AB, Neff MJ, Jurkovich GJ, Klotz P, Farver K, Ruzinski JT, Radella F, Garcia I, Maier RV. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002;236:814-822. (Pubitemid 35403237)